-
Strong rally, sharp correction: Coinbase surged between April and July 2024, but later gave back about half of those gains in a steep pullback. Today shares are up 1%
-
$300 support zone: The stock found support near $300, an area reinforced by past price reactions and the 50% Fibonacci retracement of the April–July rally.
-
Technical strength remains: Despite the correction, Coinbase continues to trade above its 100-period EMA, signaling that overall bullish sentiment is intact.
-
Upside potential: If the $300 support holds, the next resistance levels to watch are $378, and then $423—the previous highs.
-
Strong rally, sharp correction: Coinbase surged between April and July 2024, but later gave back about half of those gains in a steep pullback. Today shares are up 1%
-
$300 support zone: The stock found support near $300, an area reinforced by past price reactions and the 50% Fibonacci retracement of the April–July rally.
-
Technical strength remains: Despite the correction, Coinbase continues to trade above its 100-period EMA, signaling that overall bullish sentiment is intact.
-
Upside potential: If the $300 support holds, the next resistance levels to watch are $378, and then $423—the previous highs.
Coinbase shares remained in a strong upward trend from April through July 2024. This was followed by a sharp, deep correction that retraced roughly half of the earlier rally. However, the decline stalled around the $300 per share area, which now offers a potential base for a renewed upward move. The $300 zone has proven significant, marked by multiple prior price reactions as well as the 50% Fibonacci retracement drawn across the entire upswing that began in April this year. Moreover, the price has managed to stay above the 100-period exponential moving average, reinforcing the bullish sentiment around the stock. If the rebound from this $300 support level holds, a move towards resistance at $378 cannot be ruled out, followed by $423 per share, which corresponds to the most recent highs.
Coinbase, D1 interval
Source: xStation5
Has Alphabet just won the AI race?
MicroStrategy in trouble? Shares down 67% from the highs âś‚
Stock of the Week – NVIDIA (21.11.2025)
DE40: European tech and defence stocks sell-off
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
